PRGO Q4 2019 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.3B+10.7% YoY

Gross Profit

$481M36.3% margin

Operating Income

-$7M-0.5% margin

Net Income

-$19M-1.4% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+11.1%

Cash Flow

Operating Cash Flow

$90M

Free Cash Flow

$42M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$11.3B

Total Liabilities

$5.5B

Stockholders' Equity

$5.8B

Cash & Equivalents

$354M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+10.7%
Gross Profit	$481M	$443M	+8.5%
Operating Income	-$7M	$108M	-106.4%
Net Income	-$19M	$81M	-123.3%

Revenue Segments

Consumer Self-Care Americas

$711M54%

Consumer Self-Care International

$356M27%

RX Pharmaceuticals

$256M19%

Geographic Segments

UNITED STATES

$902M68%

Europe

$345M26%

Other Geographical Areas

$76M6%

IRELAND

$6M0%